The Future of Cell and Gene Therapy Manufacturing

Thursday, March 14, 2024

Johnson & Johnson

1000 Rte 202

Raritan, NJ 08869

6:00 PM - 9:00 PM

The upcoming event by the ISPE NJ Chapter will dive in to cell and gene therapy manufacturing with a stellar panel of industry leaders to discuss critical topics including:

Utilizing Manufacturing Platforms
Increasing Manufacturing Capacity
Techniques for Reducing Manufacturing Costs
Implementing Closed Systems
Applying Automation and Robotics
Leveraging Information Technologies such as Manufacturing Execution Systems/Electronic Batch Records and Artificial Intelligence/Machine Learning
Deploying Decentralized Manufacturing
Future Workforce and Talent Management

The event will be hosted by Johnson and Johnson with dinner and cocktails. Do not miss out on the chapter’s premier event.

Panel Moderator:

Robert Lechich, Principal Consultant, Global OT-IT Quality Services

Panelists:

Dominique DeJaeger, VP Johnson and Johnson
Innovative Medicines - Autologous Therapies Platform
Rich Bland, Senior Director of Supply Chain, Cellares
Emily Moran, Senior Vice President of Cell and Gene Manufacturing Center for Breakthrough Medicine
Ronit Slotky, PhD, Director Cell Therapies Manufacturing, Hackensack University Medical Center
Thomas Heathman, PhD, Chief Commercial Officer, Ori Biotech
David Smith, PhD, VP of Development, BioCentriq

Registration Cost

Registration $70
Sponsorship SOLD OUT